Handling relapse in smoking cessation: strategies and recommendations

Caponnetto, Pasquale; Keller, Elaine; Bruno, Cosimo Marcello; Polosa, Riccardo

doi:10.1007/s11739-012-0864-z

Cited by 38 publications

(35 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…They should receive training about dealing with everyday situations that generate trigger conditions for smoking, how to approach spouses, family members and close friends who smoke. These well-targeted strategies are important to prevent relapses [49]. …”

Section: Introductionmentioning

confidence: 99%

“…Considering that tobacco dependence is a very difficult addiction to break and that the majority of smokers typically experience multiple periods of remission and relapse, physicians must know how to cope with the withdrawal syndrome and the consequent relapse [49]. However, it is important to assess the presence and intensity of withdrawal symptoms.…”

Section: Introductionmentioning

confidence: 99%

“…Several questionnaires are useful for identifying patients that may need special care. These questionnaires include the Minnesota Nicotine Withdrawal Scale (MNWS), the Wisconsin Smoking Withdrawal Scale (WSWS) and the Cigarette Withdrawal Scale (CWS) among others [49]. …”

Section: Introductionmentioning

confidence: 99%

“…As a result, asthmatic smokers should receive specific medications for smoking cessation in a concurrent schema of behavioral techniques [49, 50]. …”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

The management of asthmatic smokers

Chatkin

Dullius

2016

asthma res and pract

View full text Add to dashboard Cite

Asthma is still a major public health problem in most countries; new strategies to better control this disease are necessary. Such strategies must include predisposing factors. One of these factors is smoking and a significant fraction of asthmatics are smokers. However, clinical trials studying new drugs or newer therapeutic regimens for asthma generally exclude smokers. Therefore, there is a lack of specific information about the treatment of asthma in smokers. The asthmatic smoker is a special phenotype with important therapeutic and prognostic clinical implications. Any form of tobacco use, especially cigarette smoking, plays an important role in this disease. Asthmatic smokers are prone to several negative outcomes. Smoking cessation results in an improvement of symptoms and pulmonary functioning. Counselling and first-line medications for smoking cessation (nicotine replacement therapy, bupropion and varenicline) significantly increase quitting rates. The role of electronic cigarettes in this group of patients has only begun to be studied. The treatment of asthmatics that smoke has characteristics that need must be well understood by clinicians, especially the poor response to corticosteroids. This condition is not universal and physicians should always consider its inclusion in the treatment of these patients. The association of inhaled corticosteroids (ICS) plus a long-acting beta2 adrenegic (LABA) by smoking asthmatics results in more pronounced improvement in several asthma outcomes compared with the use of corticosteroid alone. Inhaled corticosteroids in extra-fine particles associated with LABA may be a new perspective of treatment. Also the use of leukotriene antagonists may become another therapeutic alternative. The purpose of this narrative review is to discuss the challenges faced by clinicians to control asthma in smokers and to present methods of coping with smoking treatment and avoiding relapses.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

“…As a result, asthmatic smokers should receive specific medications for smoking cessation in a concurrent schema of behavioral techniques [49, 50]. …”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The management of asthmatic smokers

Chatkin

Dullius

2016

asthma res and pract

View full text Add to dashboard Cite

show abstract

“…Group of the Royal College of Physicians, 2007;Piasecki et al 1998;Caponnetto et al 2013c]. Consequently, many smokers will keep smoking because when given only the options of smoking or completely giving up nicotine many will not give it up.…”

Section: Long-term Nicotine Use and Smoking Abstinencementioning

confidence: 99%

Achieving appropriate regulations for electronic cigarettes

Saitta

Ferro

Polosa³

2014

Therapeutic Advances in Chronic Disease

Self Cite

View full text Add to dashboard Cite

A growing body of scientific studies show that e-cigarettes may serve as an acceptable substitute for smoking tobacco cigarettes, thereby reducing or eliminating exposure to harmful elements in smoke. The success of e-cigarettes is such that sales of these products are rapidly gaining on traditional cigarettes. The rapidly evolving phenomenon is raising concerns for the health community, pharmaceutical industry, health regulators and state governments. Obviously, these products need to be adequately regulated, primarily to protect users. Depending on the form and intended scope, certain regulatory decisions may have diverse unintended consequences on public health and may face many different challenges. Ideally, before any regulations are enacted, the regulatory body will require sufficient scientific research to verify that a problem does exist, quantify the problem, explore all potential solutions including making no change at all, determine the possible consequences of each, and then select the solution that is best for public health. Here we present an overview on the existing and deeming regulatory decisions for electronic cigarettes. We challenge them, based on the mounting scientific evidence with the ultimate goal of proposing appropriate recommendations while minimizing potential unintended consequences of ill-informed regulation.

show abstract